Computational Biology Market to Reach USD 34.87 Billion by 2030; Increase in clinical studies in pharmacogenomics and pharmacokinetics to propel growth, according to The Brainy Insights

NEWARK, New Jersey, March 22, 2022 /PRNewswire/ — According to a report published by The Brainy Insights, the global computational biology market is expected to grow from $2.96 billion in 2020 for $34.87 billion by 2030, at a CAGR of 22.7% over the forecast period 2021-2030.

Computational biology is different from biological informatics. Biological informatics is a subcategory of computer engineering and computer science that uses biology and bioengineering to build computers similar to bioinformatics.

Request a sample PDF brochure:

Computational biology includes many aspects of bioinformatics and is the science that uses biological data to develop data algorithms and analytical models to understand biological relationships and systems. Biologists did not have access to this type of data and information in the previous two decades. But in the current scenario, researchers and biologists have this type of data, especially in genomics and molecular biology. Researchers can develop statistical and analytical models to interpret recent biological information.

The increase in the number of bioinformatics researches is the main driver for the growth and development of the market in the current scenario. Bioinformatics is the subfield of bioengineering that formulates the analytical methods and software tools to understand biological data. Bioinformatics combines computer science, biology, information engineering, statistics and mathematics to analyze and interpret biological data. The emergence and advances related to the field of bioinformatics research are linked to software developments. This includes the computerized programming necessary for the manipulation and functional and structural analysis of large volumes of molecular sequences of RNA, DNA, metabolites and proteins. Pharmacogenomics has the potential to use genetic fingerprinting to predict an individual’s responses to pharmaceutical drugs in terms of efficacy, reliability, and pharmacokinetics. Pharmacogenomic applications of early phase clinical trials can recognize variations in the human genome that are significant and useful for studying participant selection and designing models for clinical research studies. Thus, this factor can boost the growth and development of the market in the current scenario.

Browse the full report with table of contents and list of figures:

Key players operating in the global computational biology market include Accelrys, Certara, Chemical Computing Group Inc, Compugen Ltd, Entelos, Genedata Ag, Insilico Biotechnology Ag, Leadscope Inc., Nimbus Discovery Llc, RhenoviaPharma Sa, Schrodinger, and Simulation Plus Inc. ., among others. To strengthen their position in the global computational biology market, the major players are now focusing on adopting strategies such as product innovations, mergers and acquisitions, recent developments, joint ventures, collaborations, and partnerships.

  • In August 2018the European Union and india Department of Biotechnology (DBT) announced the fund of $17.2 million towards research and innovation to develop the next generation influenza virus to protect individuals globally.
  • In February 2019StemoniX Inc., the U.S. provider of drug discovery and development products and services, received $14.40 million of a group of investors. Brightstone Venture Capital was the lead backer and was later joined by Crescent Ridge Partners, Alumni Ventures Group and Mayo Clinic. Similarly, in the same month, the U.S.-based Buffalo Niagara Medical Campus received funding from $5.0 million to accelerate the discovery of new drugs.

Inquiry before buying:

The contract segment led the market share by around 53% in 2020.

The services segment is divided into contract and in-house. The contract segment dominated the market share by approximately 53% in 2020. The segmental growth is attributed to the fact that contract services are cheaper than in-house services. These contracted services increase computing capabilities by eliminating considerable waste in research enterprises. With recent advancements in cloud computing and other computing technologies, contract services are expected to experience the highest growth.

The cell and biological simulation segment dominated the market with around 35% market share in 2020.

The Applications segment includes cellular and biological simulation, drug discovery and disease modeling, preclinical drug development, clinical trials, human body simulation software. The cell and biological simulation segment dominated the market with a share of approximately 35% in 2020. The growth of the segment is attributed to the fact that computational cell modeling and biological simulation helps to decipher the physiological and biological functions of cells . Rising unmet medical needs and rising demand for personalized medicine are expected to fuel segmental growth.

The academics segment is expected to witness the highest growth over the forecast period.

The market is segmented into academic, industrial and commercial by end user. The academics segment will witness the highest growth during the forecast period. The growth of the segment is mainly attributed to the increase in drug design, bioinformatics research and usage of personalized medicine in universities and research institutes.

Request personalized data:

Regional Segment Analysis of Computational Biology Market

  • North America (WE, Canada, Mexico)
  • Europe (Germany, FranceUK, Italy, SpainRest of Europe)
  • Asia Pacific (China, Japan, IndiaRest of APAC)
  • South America (Brazil and rest of South America)
  • Middle East and Africa (UNITED ARAB EMIRATES, South Africarest of the MEA)

North America The region has emerged as the largest market for the computational biology market with approximately 59% market revenue share in 2020. The regional growth is attributed to strong government initiatives and funding activities of genetic studies coupled with the increase public-private partnerships in and across the region. Additionally, industry-academia collaborations are expected to drive regional growth over the forecast period. The market in the Asia Pacific is expected to grow at the highest CAGR over the forecast period due to foreign investment and government funded population studies.

About the report:

The global computational biology market is analyzed on the basis of value (USD billion). All segments have been analyzed on a global, regional and country basis. The study includes analysis of more than 30 countries for each segment. The report offers an in-depth analysis of the drivers, opportunities, restraints and challenges to obtain key market insights. The study includes Porter’s Five Forces Model, Attractiveness Analysis, Commodity Analysis, Supply, Demand Analysis, Competitor Position Grid Analysis, distribution and marketing channel analysis.

Get access to smart ideas and our outstanding market research database.

About The Brainy Insights:

The Brainy Insights is a market research company that provides actionable insights through data analytics to improve business acumen. They have a robust forecasting and estimating model to achieve customer goals of high quality production in a short period of time. They provide both custom (customer specific) and syndicated reports. Their repository of union reports is diverse across all categories and subcategories of domains. Their customized solutions meet customer requirements, whether they are looking to expand or planning to launch a new product in the global market.

Contact us
Avinash D
Business Development Manager
Phone: +1-315-215-1633
E-mail: [email protected]

SOURCE Smart Ideas

Comments are closed.